Drugs & Therapy Perspectives | 2001(17) articles
Community-acquired pneumonia and the role of levofloxacin in its management
Immediate identification and management of anthrax essential for optimal outcome
The HMG-CoA reductase inhibitors - new safety concerns?
First reports of adverse drug reactions (ADRs) in recent weeks
New in the marketplace